Publication date: Feb 12, 2020
This pilot study aims to evaluate the feasibility of the Individual Managing Fatigue Program in people with Parkinson’s disease. The Managing Fatigue Program, a six-week, self-management energy conservation course, focuses on strategies that help people with fatigue to make changes to save and use their energy to accomplish their daily activities. Several studies have adapted and evaluated different delivery formats of the Managing Fatigue Program in conditions similar to Parkinson’s disease demonstrating that the Managing Fatigue Program is effective in reducing fatigue, depression, sleep problems, and improving quality of life, participation and self-efficacy. However, the Managing Fatigue Program is yet to be evaluated in people with Parkinson’s disease. This feasibility study, using a mixed-methods approach, nested in a pilot randomized control design, will evaluate the feasibility of the Individual Managing Fatigue Program from the perspectives of people with Parkinson’s disease, and prepare for a full-scale randomized controlled trial (RCT). This study will collect qualitative and quantitative data using feasibility, standard outcome measures, and group discussions. Using multiple recruitment strategies, 50 participants will be recruited and will be randomly assigned to two groups; n=25 in each of the experiment and control groups. The study outcome measures will be administered at three times during the study; pre-test, post-test, and a three-month follow up. The results of this study will determine whether it is feasible to do a full-scale RCT in the future. If the known beneficial effects of the Managing Fatigue program extend to the PD population, this research will be the evidence needed to support the integration of this novel solution into the care of people with PD.
- Do mobile device apps designed to support medication adherence demonstrate efficacy? A systematic review of randomised controlled trials, with meta-analysis.
- Protocol of a randomized open label multicentre trial comparing continuous intrajejunal levodopa infusion with deep brain stimulation in Parkinson’s disease – the INfusion VErsus STimulation (INVEST) study.
- The cost-effectiveness of specialized nursing interventions for people with Parkinson’s disease: the NICE-PD study protocol for a randomized controlled clinical trial.